sales@theinsightpartners.com
+1-646-491-9876 +44-20-8125-4005

Neurological Disorder Drugs Market Scope And Analysis

  • Report Code : TIPRE00004605
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Analisi del mercato dei farmaci per i disturbi neurologici e dei concorrenti entro il 2025-2031

Buy Now

Neurological Disorder Drugs Market Report Neurological Disorder Drugs Market Size and Share Neurological Disorder Drugs Market Scope and Analysis

Neurological Disorder Drugs Market Report Scope

Report Attribute Details
Market size in 2023 US$ XX million
Market Size by 2031 US$ XX Million
Global CAGR (2023 - 2031) XX%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Tipo di farmaco
  • antipsicotico
  • antiepilettico
  • anticolinergico
  • analgesici
  • ipnotico e sedativo
  • anticoagulanti
  • antipertensivi
By Tipo di malattia
  • epilessia
  • morbo di Parkinson
  • morbo di Alzheimer
  • malattia cerebrovascolare
  • sclerosi multipla
By Canale di distribuzione
  • farmacie ospedaliere
  • farmacie al dettaglio
  • farmacie online.
By Geografia
  • America del Nord
  • Europa
  • Asia-Pacifico
  • America centrale e meridionale
Regions and Countries Covered Nord America
  • Stati Uniti
  • Canada
  • Messico
Europa
  • Regno Unito
  • Germania
  • Francia
  • Russia
  • Italia
  • Resto Europa
Asia-Pacifico
  • Cina
  • India
  • Giappone
  • Australia
  • resto delAsia-Pacifico
America centrale e meridionale
  • Brasile
  • Argentina
  • Resto delAmerica Centrale e Meridionale
Medio Oriente e Africa
  • Sudafrica
  • Arabia Saudita
  • Emirati Arabi Uniti
  • Resto del Medio Oriente e Africa
Market leaders and key company profiles
  • Neurocrine Biosciences, Inc.,
  • Pfizer Inc.,
  • Biogen Inc.,
  • Teva Pharmaceutical Industries Ltd.,
  • AcelRx Pharmaceuticals, Inc.,
  • Eli Lilly and Company,
  • Adamas Pharmaceuticals, Inc.,
  • BioMarin Pharmaceutical Inc
  • AstraZeneca plc,